Return On Assets of Seres Therapeutics, Inc. from 31 Mar 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Seres Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2016 to 30 Sep 2025.
  • Seres Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 3.6%.
  • Seres Therapeutics, Inc. annual Return On Assets for 2024 was 0.06%.
  • Seres Therapeutics, Inc. annual Return On Assets for 2023 was -32%, a 59% increase from 2022.
  • Seres Therapeutics, Inc. annual Return On Assets for 2022 was -80%, a 304% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Seres Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 3.6% +12% 01 Jul 2025 30 Sep 2025
Q2 2025 55% +102% 01 Apr 2025 30 Jun 2025
Q1 2025 36% +59% 01 Jan 2025 31 Mar 2025
Q4 2024 0.06% +32% 01 Oct 2024 31 Dec 2024
Q3 2024 -8.5% +32% +79% 01 Jul 2024 30 Sep 2024
Q2 2024 -47% -0.78% -1.7% 01 Apr 2024 30 Jun 2024
Q1 2024 -22% +66% +74% 01 Jan 2024 31 Mar 2024
Q4 2023 -32% +47% +59% 01 Oct 2023 31 Dec 2023
Q3 2023 -41% +33% +45% 01 Jul 2023 30 Sep 2023
Q2 2023 -46% -15% -50% 01 Apr 2023 30 Jun 2023
Q1 2023 -88% -62% -240% 01 Jan 2023 31 Mar 2023
Q4 2022 -80% -60% -304% 01 Oct 2022 31 Dec 2022
Q3 2022 -73% -63% -614% 01 Jul 2022 30 Sep 2022
Q2 2022 -31% +11% +26% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% +12% +32% 01 Jan 2022 31 Mar 2022
Q4 2021 -20% +19% +49% 01 Oct 2021 31 Dec 2021
Q3 2021 -10% +41% +80% 01 Jul 2021 30 Sep 2021
Q2 2021 -42% +23% +36% 01 Apr 2021 30 Jun 2021
Q1 2021 -38% +13% +26% 01 Jan 2021 31 Mar 2021
Q4 2020 -39% +16% +29% 01 Oct 2020 31 Dec 2020
Q3 2020 -51% +7.3% +12% 01 Jul 2020 30 Sep 2020
Q2 2020 -65% +0.13% +0.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -51% +30% +37% 01 Jan 2020 31 Mar 2020
Q4 2019 -55% +21% +27% 01 Oct 2019 31 Dec 2019
Q3 2019 -58% +14% +19% 01 Jul 2019 30 Sep 2019
Q2 2019 -65% -12% -23% 01 Apr 2019 30 Jun 2019
Q1 2019 -81% -34% -72% 01 Jan 2019 31 Mar 2019
Q4 2018 -76% -34% -83% 01 Oct 2018 31 Dec 2018
Q3 2018 -72% -36% -99% 01 Jul 2018 30 Sep 2018
Q2 2018 -53% -15% -40% 01 Apr 2018 30 Jun 2018
Q1 2018 -47% -13% -36% 01 Jan 2018 31 Mar 2018
Q4 2017 -41% -11% -36% 01 Oct 2017 31 Dec 2017
Q3 2017 -36% -6.2% -21% 01 Jul 2017 30 Sep 2017
Q2 2017 -38% -7.3% -24% 01 Apr 2017 30 Jun 2017
Q1 2017 -35% -4.1% -14% 01 Jan 2017 31 Mar 2017
Q4 2016 -30% 01 Oct 2016 31 Dec 2016
Q3 2016 -30% 01 Jul 2016 30 Sep 2016
Q2 2016 -30% 01 Apr 2016 30 Jun 2016
Q1 2016 -31% 01 Jan 2016 31 Mar 2016

Seres Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 0.06% +32% 01 Jan 2024 31 Dec 2024
2023 -32% +47% +59% 01 Jan 2023 31 Dec 2023
2022 -80% -60% -304% 01 Jan 2022 31 Dec 2022
2021 -20% +19% +49% 01 Jan 2021 31 Dec 2021
2020 -39% +16% +29% 01 Jan 2020 31 Dec 2020
2019 -55% +21% +27% 01 Jan 2019 31 Dec 2019
2018 -76% -34% -83% 01 Jan 2018 31 Dec 2018
2017 -41% -11% -36% 01 Jan 2017 31 Dec 2017
2016 -30% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.